Sarah Clements
Algemeen Adviseur bij INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A.
Profiel
Sarah Clements is currently the General Counsel at International Consolidated Airlines Group SA and a Trustee at Solent Mind.
She previously worked as the Senior Vice President at GSK Plc and as the Vice President-Legal & International at Alexion Pharmaceuticals, Inc. Ms. Clements completed her undergraduate degree at Newcastle University.
Actieve functies van Sarah Clements
Bedrijven | Functie | Begin |
---|---|---|
INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A. | Algemeen Adviseur | 01-11-2022 |
Solent Mind
Solent Mind Miscellaneous Commercial ServicesCommercial Services Solent Mind is a mental health charity based in Hampshire, UK. The British company provides emotional wellbeing and mental health support for people living in the area. The non-profit company aims to fight against stigma and inspire others to care for their mental health. Sally Arscott has been the CEO of the company since 2022. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Sarah Clements
Bedrijven | Functie | Einde |
---|---|---|
GSK PLC | Corporate Officer/Principal | 01-11-2022 |
ALEXION PHARMACEUTICALS, INC. | Algemeen Adviseur | - |
Opleiding van Sarah Clements
Newcastle University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A. | Transportation |
GSK PLC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Solent Mind
Solent Mind Miscellaneous Commercial ServicesCommercial Services Solent Mind is a mental health charity based in Hampshire, UK. The British company provides emotional wellbeing and mental health support for people living in the area. The non-profit company aims to fight against stigma and inspire others to care for their mental health. Sally Arscott has been the CEO of the company since 2022. | Commercial Services |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |